Evofem Biosciences to Present at Jefferies Virtual Healthcare Conference 2021

<br /> Evofem Biosciences to Present at Jefferies Virtual Healthcare Conference 2021<br />

PR Newswire


SAN DIEGO

,

June 1, 2021

/PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ:

EVFM

) today announced that

Saundra Pelletier

, Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows:


Date:


Friday, June 4, 2021


Time:


10:30 a.m. ET (7:30 a.m. PT)


Webcast:



https://wsw.com/webcast/jeff174/evfm/1851714

The presentation will be webcast live and archived for 30 days thereafter.


About Evofem Biosciences


Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company launched its first FDA-approved commercial product,

Phexxi

®

(lactic acid, citric acid and potassium bitartrate), in the United States in September 2020. The Company is evaluating lead product candidate EVO100 for the prevention of urogenital

Chlamydia trachomatis

and

Neisseria gonorrhoeae

infection in women in the ongoing Phase 3 clinical trial,

‘EVOGUARD

.’ For more information, please visit

evofem.com

.


Phexxi

®

is a registered trademark of Evofem Biosciences, Inc.


Investor Relations Contact



Amy Raskopf


Evofem Biosciences, Inc.



[email protected]



Mobile: (917) 673-5775

Cision
View original content to download multimedia:

http://www.prnewswire.com/news-releases/evofem-biosciences-to-present-at-jefferies-virtual-healthcare-conference-2021-301302444.html

SOURCE Evofem Biosciences, Inc.

If You Liked This Article Click To Share

Biotech